When your golden dose of Mounjaro stops working – or never quite did

You've hit 10mg – or 12.5mg, or wherever the wheels came off

Picture this: you spent weeks titrating carefully, the appetite suppression finally felt real, weight was moving, and then one pen in – nothing. Or worse, the effect that made you feel genuinely different has quietly faded over a month or two. It's a familiar story.

Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) that regulate fullness signals and slow the rate at which the stomach empties. At its most effective, that dual action reduces overall calorie intake without you consciously fighting hunger. The NHS medicines guidance on tirzepatide notes that the medicine is taken alongside a reduced-calorie diet and increased activity – which matters here, because the medicine modulates appetite; it doesn't override every other variable in your life.

When the effect seems to have disappeared, the first question isn't "has my dose stopped working?" – it's "has something else changed?" Disrupted sleep, a period of high stress, illness, a holiday where eating patterns shifted, or gradual dietary drift back toward higher-calorie foods can all reduce the visible effect of the same dose. These factors don't mean you've failed; they mean you're human. Most people find the effect restores once the surrounding factors settle. If you're unsure whether yours have, the overview of how Mounjaro works explains the mechanisms in more detail.

Is this a tolerance effect – and what does the evidence say?

The concept of "tolerance" gets applied a lot in online forums, often loosely. What the clinical trial data actually show is more nuanced. In SURMOUNT-1, which followed thousands of adults over 72 weeks at the highest tirzepatide doses, average weight loss continued to accumulate through the trial rather than plateauing sharply at a fixed point – though the rate of loss does naturally slow as body weight falls and energy requirements adjust downward. That's biology, not the medicine becoming inert.

What can happen is that the dose you're on remains pharmacologically active but your body's calorie requirements have shifted enough that weight loss stalls even with good appetite control. A lower body weight needs fewer calories to maintain – so a deficit that produced visible results at 100kg may look much smaller at 85kg. NICE's appraisal of tirzepatide (TA1026) flags that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be reviewed by a prescriber. That review, though, is a clinical conversation – not an automatic instruction to stop.

For some people, the right next step is titrating to the next strength. If you're on 10mg and results have stalled, what to do when 10mg Mounjaro isn't working covers the specific picture at that dose. Others may find the answer sits in the lifestyle side of the equation rather than the prescription itself.

Practical things worth checking before your next review

Before concluding the dose has failed, it's worth running through a short honest audit. Are you eating noticeably more than a month ago – even healthy foods? Has your activity level dropped? Have you had a run of poor sleep, which is independently associated with increased hunger signalling? Are you drinking enough water? Dehydration can mimic hunger and quietly undermine what tirzepatide is doing.

Protein adequacy matters particularly on tirzepatide because appetite suppression can reduce total food volume to a point where protein falls short of what's needed to protect muscle during weight loss. Less muscle means a lower basal metabolic rate over time – which can make a plateau feel like a medicine failure when it's actually a nutrition gap. A prescriber or dietitian can help you assess this.

For a sense of where your current weight sits relative to the treatment goals, the NHS BMI calculator is a useful baseline reference. And if cost is a concern while you're working through this, the Mounjaro cost context page explains what private treatment realistically involves.

One more thing worth raising: if you've recently started a new medication or changed how you take an existing one, some medicines interact with tirzepatide's absorption profile. That's a conversation for your prescriber, not a forum.

What to do if you genuinely feel the dose isn't right

The clinical pathway is straightforward, even if the decision isn't always easy. Contact your prescriber and describe what you're seeing: how many weeks at this dose, what changed and when, what your current weight is, and what your diet and activity look like. A good prescriber will ask all of this before making any recommendation.

Options typically considered include: staying at the current dose with targeted lifestyle adjustments, titrating to the next available strength, or reviewing whether the broader treatment plan needs updating. If you're at 12.5mg and still not seeing movement, the picture at the highest 15mg dose is worth understanding before your review conversation. Equally, some people find reviewing what happened at earlier doses is clarifying, and the 5mg experience and what it tells you about your individual response can provide useful context alongside the 7.5mg experience.

At nume, every repeat order is reviewed by a real prescriber before it's dispensed – not processed automatically. If something isn't working, that review is the right moment to say so. Speak to our prescribers through a free consultation to talk through what's happening and what the right next step looks like for you specifically.